相关实验视频

Updated: Jun 10, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

68.0K

比克特格拉维尔在体内改变葡萄糖耐受性,并导致肝脏线粒体功能障碍

Patricia García-Martínez1, Laura Gisbert-Ferrándiz1, Ángeles Álvarez2

  • 1Departamento de Farmacología, Universitat de València, Valencia, Spain; Fundación para El Fomento de La Investigación Sanitaria y Biomédica en La Comunidad Valenciana (FISABIO)-Hospital Universitario Doctor Peset, Valencia, Spain.

Antiviral research
|October 16, 2024
PubMed
概括

比克特格拉维尔 (BIC) 是一种整合酶抑制剂,它可能通过影响葡萄糖代谢,导致艾滋病毒感染者的线粒体压力,从而导致胰岛素抵抗和糖尿病. 需要进一步的临床研究.

关键词:
这就是Bictegravir.多卢特格拉维尔 (Dolutegravir) 是一种药物.葡萄糖的新陈代谢.艾滋病毒并发症 艾滋病毒并发症肝细胞 肝细胞 肝细胞胰岛素耐药性 胰岛素耐药性是一种

更多相关视频

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

10.9K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
178
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
163